The relationship between various laboratory findings and the results of LSGB in a cohort of patients suspected of having SS, including ANA, RF, and the specific SS-related antibodies (anti-Ro and anti-La), were categorized as either "suggestive" or "non-suggestive" of SS, and the statistical significance of the associations between these antibodies and biopsy outcomes was evaluated using P-values (Table 2). Here, BTG3 is linked to synovial sarcoma.